Infliximab is an appropriate second‐line therapy in infants with steroid refractory pyoderma gangrenosum. (27th January 2022)
- Record Type:
- Journal Article
- Title:
- Infliximab is an appropriate second‐line therapy in infants with steroid refractory pyoderma gangrenosum. (27th January 2022)
- Main Title:
- Infliximab is an appropriate second‐line therapy in infants with steroid refractory pyoderma gangrenosum
- Authors:
- Lesmeister, L.M.
Peitz, J.
von Kleist‐Retzow, J.C.
Lee‐Kirsch, M.A.
Torrelo, A.
Tantcheva‐Poor, I.
Broekaert, I.J. - Abstract:
- Is Part Of:
- Journal of the European Academy of Dermatology and Venereology. Volume 36:Number 5(2022)
- Journal:
- Journal of the European Academy of Dermatology and Venereology
- Issue:
- Volume 36:Number 5(2022)
- Issue Display:
- Volume 36, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 36
- Issue:
- 5
- Issue Sort Value:
- 2022-0036-0005-0000
- Page Start:
- e376
- Page End:
- e378
- Publication Date:
- 2022-01-27
- Subjects:
- Dermatology -- Periodicals
Sexually transmitted diseases -- Periodicals
616.5 - Journal URLs:
- https://onlinelibrary.wiley.com/journal/14683083 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=jdv ↗
http://www.sciencedirect.com/science/journal/09269959 ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0926-9959;screen=info;ECOIP ↗
http://www.blackwell-synergy.com/loi/jdv ↗ - DOI:
- 10.1111/jdv.17921 ↗
- Languages:
- English
- ISSNs:
- 0926-9959
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4741.624000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21870.xml